Reply to Isabel Heidegger and Jasmin Bektic's Letter to the Editor re: Michael Baboudjian, Riccardo Leni, Marco Oderda, et al., Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European Cohort. Eur Urol Oncol. 2025;8:1257-1263.
APA
Baboudjian M, Ploussard G (2025). Reply to Isabel Heidegger and Jasmin Bektic's Letter to the Editor re: Michael Baboudjian, Riccardo Leni, Marco Oderda, et al., Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European Cohort. Eur Urol Oncol. 2025;8:1257-1263.. European urology oncology, 8(5), 1450. https://doi.org/10.1016/j.euo.2025.05.005
MLA
Baboudjian M, et al.. "Reply to Isabel Heidegger and Jasmin Bektic's Letter to the Editor re: Michael Baboudjian, Riccardo Leni, Marco Oderda, et al., Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European Cohort. Eur Urol Oncol. 2025;8:1257-1263.." European urology oncology, vol. 8, no. 5, 2025, pp. 1450.
PMID
40410051